Fei Si-Fan, Tong De-Bing, Jia Fang
Department of Cardiovascular Medicine, The First People's Hospital of Changzhou, The Third Affiliated Hospital of Soochow University, 213000 Changzhou, Jiangsu, China.
Rev Cardiovasc Med. 2023 Mar 23;24(4):97. doi: 10.31083/j.rcm2404097. eCollection 2023 Apr.
Atherosclerotic cardiovascular disease is currently the leading cause of death worldwide. Its pathophysiological basis includes endothelial dysfunction, macrophage activation, vascular smooth muscle cell (VSMC) proliferation, lipid metabolism, platelet aggregation, and changes in the gut microbiota. Salidroside has beneficial effects on atherosclerosis through multiple pathways. In this review, we present studies on the regulatory effect of salidroside on atherosclerosis. Furthermore, we report the protective effects of salidroside against atherosclerosis by ameliorating endothelial dysfunction, suppressing macrophage activation and polarization, inhibiting VSMC proliferation, adjusting lipid metabolism, attenuating platelet aggregation, and modulating the gut microbiota. This review provides further understanding of the molecular mechanism of salidroside and new ideas for atherosclerosis management.
动脉粥样硬化性心血管疾病是目前全球主要的死亡原因。其病理生理基础包括内皮功能障碍、巨噬细胞活化、血管平滑肌细胞(VSMC)增殖、脂质代谢、血小板聚集以及肠道微生物群的变化。红景天苷通过多种途径对动脉粥样硬化具有有益作用。在本综述中,我们展示了关于红景天苷对动脉粥样硬化调节作用的研究。此外,我们报道了红景天苷通过改善内皮功能障碍、抑制巨噬细胞活化和极化、抑制VSMC增殖、调节脂质代谢、减轻血小板聚集以及调节肠道微生物群来预防动脉粥样硬化的保护作用。本综述为进一步理解红景天苷的分子机制以及动脉粥样硬化的管理提供了新思路。